Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/43344
Type
ArticleCopyright
Open access
Collections
- BA - IGM - Artigos de Periódicos [3814]
- IOC - Artigos de Periódicos [12978]
Metadata
Show full item record
TRACKING THE ONSET DATE OF THE COMMUNITY SPREAD OF SARS-COV-2 IN WESTERN COUNTRIES
Disseminação pela comunidade
Europa
América
COVID-19
Rede Genômica Fiocruz
GENOMAHCOV
https://www.arca.fiocruz.br/handle/icict/41454
Affilliation
Universidade Federal do Espírito Santo. Centro de Ciências Exatas, Naturais e da Saúde. Departamento de Biologia. Alegre, ES, Brasil.
Universidad de la República. Centro Universitario Regional del Litoral Norte. Unidad de Genómica y Bioinformática. Salto, Uruguay.
Fundação Oswaldo Cruz. instituto Gonçalo Moniz. Salvador, BA, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
Universidad de la República. Centro Universitario Regional del Litoral Norte. Unidad de Genómica y Bioinformática. Salto, Uruguay.
Fundação Oswaldo Cruz. instituto Gonçalo Moniz. Salvador, BA, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly spread around the world during 2020, but the precise
time in which the virus began to spread locally is difficult to trace for most countries. Here, we estimate the probable onset
date of the community spread of SARS-CoV-2 for heavily affected countries from Western Europe and the Americas on the
basis of the cumulative number of deaths reported during the early stage of the epidemic. Our results support that SARS-CoV-2
probably started to spread locally in all western countries analysed between mid-January and mid-February 2020, thus long
before community transmission was officially recognised and control measures were implemented.
Keywords in Portuguese
SARS-CoV-2Disseminação pela comunidade
Europa
América
COVID-19
Rede Genômica Fiocruz
GENOMAHCOV
Share